Angela A. Armstrong

Array ( [id] => 6996724 [patent_doc_number] => 20050136502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Treatment of disorders associated with elevated blood glucose or blood pressure' [patent_app_type] => utility [patent_app_number] => 11/016110 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23014 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136502.pdf [firstpage_image] =>[orig_patent_app_number] => 11016110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7018690 [patent_doc_number] => 20050220709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy' [patent_app_type] => utility [patent_app_number] => 11/003306 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20648 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220709.pdf [firstpage_image] =>[orig_patent_app_number] => 11003306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983821 [patent_doc_number] => 20050153891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Viral protein binding compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/000358 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6847 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153891.pdf [firstpage_image] =>[orig_patent_app_number] => 11000358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040333 [patent_doc_number] => 20050159352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Use of monocarboxylate transporter protein for thyroid hormone transport' [patent_app_type] => utility [patent_app_number] => 10/997757 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9440 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159352.pdf [firstpage_image] =>[orig_patent_app_number] => 10997757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786137 [patent_doc_number] => 20080139466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Dna Sequence and Expressed Recombinant Glycoproteins Related to Feline Thyrotropin' [patent_app_type] => utility [patent_app_number] => 10/579090 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17379 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139466.pdf [firstpage_image] =>[orig_patent_app_number] => 10579090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4464989 [patent_doc_number] => 07935793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Treatment of inflammatory bowel diseases with anti-IP-10 antibodies' [patent_app_type] => utility [patent_app_number] => 10/581468 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 19000 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935793.pdf [firstpage_image] =>[orig_patent_app_number] => 10581468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996677 [patent_doc_number] => 20050136455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Soluble transferrin receptor' [patent_app_type] => utility [patent_app_number] => 10/971870 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20364 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136455.pdf [firstpage_image] =>[orig_patent_app_number] => 10971870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145278 [patent_doc_number] => 20050119181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Hydrophobically-modified protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/956724 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 33608 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119181.pdf [firstpage_image] =>[orig_patent_app_number] => 10956724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161450 [patent_doc_number] => 20050084911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby' [patent_app_type] => utility [patent_app_number] => 10/947444 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12682 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084911.pdf [firstpage_image] =>[orig_patent_app_number] => 10947444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083804 [patent_doc_number] => 20050049184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Treatments which elevate functional glycosylated leptin trasnport factor, for controlling weight and obesity' [patent_app_type] => utility [patent_app_number] => 10/938049 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11984 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049184.pdf [firstpage_image] =>[orig_patent_app_number] => 10938049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107924 [patent_doc_number] => 20070066802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Chimeric receptors with disrupted dileucine motifs' [patent_app_type] => utility [patent_app_number] => 10/568235 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7739 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066802.pdf [firstpage_image] =>[orig_patent_app_number] => 10568235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971723 [patent_doc_number] => 20050037433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'p16 mediated regulation of NMDA receptors' [patent_app_type] => utility [patent_app_number] => 10/914669 [patent_app_country] => US [patent_app_date] => 2004-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15929 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037433.pdf [firstpage_image] =>[orig_patent_app_number] => 10914669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880893 [patent_doc_number] => 20060029976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Method for the detection of C-reactive protein in mammalian fluids' [patent_app_type] => utility [patent_app_number] => 10/913082 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2308 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029976.pdf [firstpage_image] =>[orig_patent_app_number] => 10913082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127345 [patent_doc_number] => 20050059089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Complexes of GPCR142 and relaxin3 or INSL5, and their production and use' [patent_app_type] => utility [patent_app_number] => 10/913713 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19966 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059089.pdf [firstpage_image] =>[orig_patent_app_number] => 10913713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427936 [patent_doc_number] => 20040229933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Treatment of hypertension' [patent_app_type] => new [patent_app_number] => 10/782021 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7233 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229933.pdf [firstpage_image] =>[orig_patent_app_number] => 10782021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5888823 [patent_doc_number] => 20060275835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods for identifying cell surface receptor protein modulators' [patent_app_type] => utility [patent_app_number] => 10/563692 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31085 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275835.pdf [firstpage_image] =>[orig_patent_app_number] => 10563692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 590904 [patent_doc_number] => 07435808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2' [patent_app_type] => utility [patent_app_number] => 10/874923 [patent_app_country] => US [patent_app_date] => 2004-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 151443 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435808.pdf [firstpage_image] =>[orig_patent_app_number] => 10874923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889782 [patent_doc_number] => 20060276388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Hip/pap polypeptide compositions for use in liver regeneration and for the prevention of liver failure' [patent_app_type] => utility [patent_app_number] => 10/561034 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15681 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276388.pdf [firstpage_image] =>[orig_patent_app_number] => 10561034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177378 [patent_doc_number] => 20070178438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Apolipoprotein c-1 induced apoptosis' [patent_app_type] => utility [patent_app_number] => 10/557283 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26782 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178438.pdf [firstpage_image] =>[orig_patent_app_number] => 10557283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159402 [patent_doc_number] => 20070172446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Synthetic chemokine receptor ligands and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/555735 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 56162 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172446.pdf [firstpage_image] =>[orig_patent_app_number] => 10555735 [rel_patent_id] =>[rel_patent_doc_number] =>)